The Article related to alzheirmers disease pyridazinone cholinesterases inhibitor mol modeling, 3(2h)-pyridazinone, ache inhibitor, bche inhibitor, hydrazone, molecular modelling, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Synthetic Route of 321-28-8
On December 31, 2019, Ozcelik, Azime Berna; Ozdemir, Zeynep; Sari, Suat; Utku, Semra; Uysal, Mehtap published an article.Synthetic Route of 321-28-8 The title of the article was A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies. And the article contained the following:
AChE and BChE are known to be serine hydrolase enzymes responsible for the hydrolysis of ACh. Here, we prepared 12 new 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(nonsubstituted/4-substituted benzenesulfonohydrazide) derivatives and evaluated their inhibitory effects on AChE/BChE in pursuit of potent dual inhibitors for Alzheirmer’s Disease. We also tried to get insights into binding interactions of the synthesized compounds in the active site of both enzymes by using mol. docking approach. We obtained our compounds by the reaction of various substituted/nonsubstituted benzenesulfonic acid derivatives with 6-substitutedphenyl-3(2H)-pyridazinone-2-yl acetohydrazide and determined their anticholinesterase activities according to the Ellman’s method. Mol. docking studies were done using Glide and the results were evaluated on Maestro. The title compounds showed moderate inhibition at 100渭g/mL against both enzymes, yet with better activity against BChE. Compound VI2a emerged as a dual inhibitor with 25.02% and 51.70% inhibition against AChE and BChE, resp. This study supports that novel pyridazinone derivates may be used for the development of new BChE inhibitory agents. It was less potent than the reference drugs, yet promising for further modifications as a lead. The ability of the compounds to adopt energetically more favorable conformations and to engage in more key interactions in the ECBChE active gorge explains their better activity profile against ECBChE. The experimental process involved the reaction of 1-Fluoro-2-methoxybenzene(cas: 321-28-8).Synthetic Route of 321-28-8
The Article related to alzheirmers disease pyridazinone cholinesterases inhibitor mol modeling, 3(2h)-pyridazinone, ache inhibitor, bche inhibitor, hydrazone, molecular modelling, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Synthetic Route of 321-28-8
Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem